Fuso Chemical (4368) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
24 Mar, 2026Executive summary
Net sales for the three months ended June 30, 2024, rose 27.8% year-over-year to ¥17,431 million.
Operating profit increased 22.4% year-over-year to ¥3,910 million.
Ordinary profit grew 15.1% year-over-year to ¥4,290 million.
Profit attributable to owners of parent rose 17.5% year-over-year to ¥2,884 million.
Comprehensive income increased 15.6% year-over-year to ¥3,775 million.
Financial highlights
Gross profit for the quarter was ¥6,242 million, up from ¥5,559 million year-over-year.
Operating profit before depreciation and amortization reached ¥5,729 million, up from ¥4,180 million year-over-year.
Earnings per share for the quarter were ¥81.83, compared to ¥69.63 a year earlier.
Total assets as of June 30, 2024, were ¥136,171 million, up from ¥133,740 million at the previous fiscal year-end.
Net assets increased to ¥97,644 million, with an equity ratio of 71.7%.
Outlook and guidance
Full-year net sales forecast for FY2025 is ¥68,000 million, up 15.3% year-over-year.
Full-year operating profit is projected at ¥13,500 million, up 21.8% year-over-year.
Profit attributable to owners of parent is forecast at ¥9,150 million, up 9.7% year-over-year.
Full-year EPS is expected to reach ¥259.57.
Dividend forecast remains unchanged at ¥66.00 per share for the year.
Latest events from Fuso Chemical
- Record half-year profit and sales growth driven by semiconductors, but FX hit comprehensive income.4368
Q2 202524 Mar 2026 - Record-high sales and profits, with next year’s guidance projecting lower earnings but higher dividends.4368
Q4 202524 Mar 2026 - Strong year-over-year growth in sales and profits, with robust outlook for the full year.4368
Q3 202524 Mar 2026 - Record-high sales and profits with strong outlook, led by semiconductor demand and expansion.4368
Q2 202624 Mar 2026 - Quarterly sales and profits rose, but comprehensive income fell due to currency effects.4368
Q1 202624 Mar 2026 - Strong year-over-year growth in sales, profits, and margins with a positive full-year outlook.4368
Q3 202624 Mar 2026